Résumé
Les tumeurs stromales gastro-intestinales (GIST) peuvent être situées n’importe où dans le tractus gastrointestinal. Les symptômes révélateurs sont consécutifs à ces complications : obstruction, hémorragie, perforation. Les GIST doivent être considérées comme à potentiel de malignité. La résection chirurgicale complète (R0) est le seul traitement potentiellement curatif. Nous présentons le cas d’une péritonite généralisée par GIST perforé du grêle, dans l’anse bilio-pancréatique du bypass gastrique.
Abstract
Gastrointestinal stromal tumors (GIST) can be located anywhere in the gastrointestinal tract. The revealing symptoms are resulting from complications: obstruction, bleeding perforation. All GIST should be considered to have a malignant potential. Complete surgical resection (R0) is the only potentially curative treatment. We present the case of generalized peritonitis due to a perforated GIST located in the bilio-pancreatic limb of a gastric bypass.
This is a preview of subscription content, log in via an institution to check access.
Références
Mazur MT, Clark HB (1983) Gastric stromal tumors. Reappraisal of histogenesis. Am J Surg Pathol 7:507–519
Burkill GJ (2003) Malignant gastrointestinal, stromal tumor: Distribution, imaging features, and pattern of metastatic spread. Radiology 226:527–532
Tran T, Davila JA, El-Serag HB (2005) The epidemiology of malignant gastrointestinal stromal tumors: An analysis of 1,458 cases from 1992 to 2000. Am J Gastroenterol 100:162–168
Hasegawa T, Matsuno Y, Shimoda T, Hirohashi S. (2002) gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade. Hum Pathol 33:669–676
Nishida T (2003) Multidetector CT of high risk patients with occult gastrointestinal stromal tumors. AJR 180:185–189
Kindblom LG (2003) Gastrointestinal stromal tumors; diagnosis epidemiology, prognosis. ASCO Annual Meeting. Chicago
Levy AD (2004) Gastrointestinalstromal tumors in patients with neurofibromatosis: Imaging features with clinicopathologic correlation. AJR 183:1629–1636
De Matteo RP, Lewis JJ, Leung D, et al (2000)Two hundred gastrointestinal stromal tumors: Recurrence patterns and prognostic factors for survival. Ann Surg 231:51–58
Demetri GD (2002) Identification and tratment of chemoresistant inoperable or metastasic GIST: experience with a selective tyrosine kinase inhibitor imatinib mesylate. Eur J Cancer 38:S52–S59
Logan-Collins JM (2008) Gastric Tumeurs. In The Mont Reid Surgical Handbook, Wolfgang Stehr MD, Sixth Edition, Saunders Elsevier, p.601–610
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Barros, F., Chevre, F., Becciolini, C. et al. Tumeur stromale gastro-intestinale (GIST) du grêle perforée chez un patient avec bypass gastrique : cas clinique. Obes 9, 299–301 (2014). https://doi.org/10.1007/s11690-014-0422-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11690-014-0422-4